...
首页> 外文期刊>Journal of Medicinal Chemistry >New nucleotide-competitive non-nucleoside inhibitors of terminal deoxynucleotidyl transferase: Discovery, characterization, and crystal structure in complex with the target
【24h】

New nucleotide-competitive non-nucleoside inhibitors of terminal deoxynucleotidyl transferase: Discovery, characterization, and crystal structure in complex with the target

机译:新型的末端脱氧核苷酸转移酶的核苷酸竞争性非核苷抑制剂:与靶标复合的发现,表征和晶体结构

获取原文
获取原文并翻译 | 示例

摘要

Terminal deoxynucletidyl transferase (TdT) is overexpressed in some cancer types, where it might compete with pol μ during the mutagenic repair of double strand breaks (DSBs) through the nonhomologous end joining (NHEJ) pathway. Here we report the discovery and characterization of pyrrolyl and indolyl diketo acids that specifically target TdT and behave as nucleotide-competitive inhibitors. These compounds show a selective toxicity toward MOLT-4 compared to HeLa cells that correlate well with in vitro selectivity for TdT. The binding site of two of these inhibitors was determined by cocrystallization with TdT, explaining why these compounds are competitive inhibitors of the deoxynucleotide triphosphate (dNTP). In addition, because of the observed dual localization of the phenyl substituent, these studies open the possibility of rationally designing more potent compounds.
机译:末端脱氧核糖核酸转移酶(TdT)在某些类型的癌症中过表达,在通过非同源末端连接(NHEJ)途径诱变修复双链断裂(DSB)的过程中,末端脱氧核糖核酸转移酶可能与polμ竞争。在这里,我们报告发现和表征的吡咯基和吲哚基二酮酸,专门针对TdT,并表现为核苷酸竞争性抑制剂。与HeLa细胞相比,这些化合物对MOLT-4具有选择性毒性,而HeLa细胞与TdT的体外选择性密切相关。通过与TdT共结晶来确定其中两种抑制剂的结合位点,从而解释了为什么这些化合物是脱氧核苷酸三磷酸(dNTP)的竞争性抑制剂。另外,由于观察到苯基取代基的双重定位,这些研究为合理设计更有效的化合物提供了可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号